Stroke remains a leading cause of mortality and disability worldwide. Early recognition and prompt management are crucial to improving outcomes. This brief review aims to provide an overview of the essential strategies for early stroke recognition and management in clinical practice.
The acronym FAST (Face, Arms, Speech, Time) is a vital tool for early stroke recognition. It highlights the importance of quick response to the sudden onset of facial drooping, arm weakness, and speech difficulties. Time is a critical factor, reminding healthcare professionals that every minute counts when it comes to stroke treatment.
The first 60 minutes following a stroke, often referred to as the 'Golden Hour,' are critical for patient prognosis. Immediate management includes stabilizing vital signs, performing a neurological evaluation, and initiating reperfusion therapy, if indicated. Intravenous thrombolysis with recombinant tissue plasminogen activator (rt-PA) remains the standard of care for eligible patients.
Secondary prevention strategies are vital to reducing stroke recurrence. These include managing hypertension, diabetes, and dyslipidemia, promoting a healthy lifestyle, and initiating antithrombotic therapy. Patient education is also crucial, emphasizing the importance of medication adherence and regular follow-up.
Early recognition and prompt management of stroke can significantly improve patient outcomes. The FAST acronym is a practical tool for early recognition, while immediate management and secondary prevention strategies are key to reducing mortality and disability. As healthcare professionals, we must remain vigilant and proactive in our approach to this devastating condition.
1.
FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug
2.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
3.
Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.
4.
Never in a million years did I think I'd have to limit my chemotherapy.
5.
Treating Depression: Crucial for Recovery From Fibromyalgia
1.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
2.
Clinical Analysis of Prostate Cancer
3.
Sorafenib: Understanding the science behind a powerful cancer drug
4.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
5.
Comprehensive Breakthroughs in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation